New robotic arm exoskeleton aims to restore daily function after stroke or nerve injury

NCT ID NCT07000279

Recruiting now Symptom relief Sponsor: Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study is testing a portable hybrid exoskeleton that combines a robotic arm support with electrical stimulation to help people with upper limb deficits from stroke or brachial plexus injuries. Ten participants will perform tasks like moving blocks and daily activities with and without the device to see if it improves movement and usability. The goal is to assess safety, performance, and user satisfaction.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: hybrid assistive exoskeleton (robotic exoskeleton plus functional electrical stimulation)
What this could lead to: If it works, this device could help people with arm weakness regain independence in daily activities like eating and drinking.
What could go wrong: This is a very small pilot study with only 10 participants, so results may not apply to everyone. The device is still experimental and may have technical issues or not provide enough benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRACHIAL PLEXUS INJURIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brachial plexus neuropathy from injury stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

UPPER LIMB DEFICITS

Contacts and locations

Locations

Centro Protesi Inail
RECRUITING

Budrio, Bologna, 40054, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.